Lv31
298 积分 2023-06-15 加入
Obinutuzumab may be an effective and safe option for adult minimal change disease and focal segmental glomerulosclerosis patients after multitarget therapy including rituximab
18天前
已完结
T cell costimulatory blockade ameliorates induction of experimental membranous nephropathy potentially through T-helper 17 cell suppression in the kidney
1个月前
已完结
Non-Invasive Diagnostic Strategies for Membranous Nephropathy in the NEPTUNE Study
1个月前
已完结
Shen-Qi-Di-Huang Decoction induces autophagy in podocytes to ameliorate membranous nephropathy by suppressing USP14
2个月前
已完结
PLA2R autoantibodies, a multifaceted biomarker in nephrotic syndrome and membranous nephropathy
2个月前
已完结
Microparticle-Assisted Protein Capture Method Facilitates Proteomic and Glycoproteomic Analysis of Urine Samples
2个月前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
5个月前
已完结
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series
5个月前
已完结
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy
5个月前
已完结
A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry
5个月前
已完结
皖公网安备34019202002308
